In, Haejin <br/><br/>
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.  [electronic resource] 

 -  Annals of surgical oncology  06 2016 
 - 1956-62 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-015-5075-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy, Adjuvant--mortality<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Gastrectomy--mortality<br/>Humans<br/>Lymph Node Excision--mortality<br/>Lymph Nodes--pathology<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy--mortality<br/>Prognosis<br/>Retrospective Studies<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate